Red Cell Distribution Width Predicts Surgical Complications

This article originally appeared here.
Share this content:
Red Cell Distribution Width Predicts Surgical Complications
Red Cell Distribution Width Predicts Surgical Complications

WEDNESDAY, April 5, 2017 (HealthDay News) -- In children undergoing adenotonsillectomy for sleep-disordered breathing, preoperative elevated red cell distribution width is associated with an increased risk of respiratory adverse events, according to research published online March 27 in Pediatric Anesthesia.

Betul Kozanhan, M.D., from the Education and Research Hospital, and Mehmet S. Iyisoy, from Necmettin Erbakan University, both in Konya, Turkey, evaluated whether elevated red cell distribution width is associated with postoperative respiratory adverse events in 287 consecutive children (mean age, 7.49 years) undergoing elective adenotonsillectomy for treatment of sleep-disordered breathing.

The researchers found that the frequency of respiratory complications was 22.3 percent during emergence and 20.14 percent in the postanesthesia care unit. Mean red cell distribution width was higher in patients with complications versus those without complications (14.36 versus 13.53). Red cell distribution width had an adjusted odds ratio of 7.28 and an area under the curve value of 0.74 in predicting postoperative complications. A cut-off value of 14.7 for red cell distribution width was found.

"Our study showed that preoperative elevated red cell distribution width is associated with an increased risk of respiratory adverse events in children undergoing adenotonsillectomy for sleep-disordered breathing," the authors write.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »


Sign up for myCME e-newsletters


Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions

More in Home

FDA Approves Kinase Inhibitor for Treatment of AML

FDA Approves Kinase Inhibitor for Treatment of AML

Midostaurin, in combination with chemotherapy, treats acute myeloid leukemia in adults

Enzyme Replacement Drug OK'd for Form of Batten Disease

Enzyme Replacement Drug OK'd for Form of Batten ...

Brineura will be used to treat children with late infantile neuronal ceroid lipofuscinosis type 2 Batten

is free, fast, and customized just for you!

Already a member?

Sign In Now »